Investors with an interest in Medical - Products stocks have likely encountered both EssilorLuxottica Unsponsored ADR (ESLOY) and LeMaitre Vascular (LMAT). But which of these two stocks is more ...
Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report) today and set a price target of $100.00. The company’s shares closed yesterday at $88.39. Wise ...
In a report released today, Michael Petusky from Barrington maintained a Hold rating on Lemaitre Vascular (LMAT – Research Report). The company’s shares opened today at $50.86. Petusky covers the ...
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.40 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results